Michael has spent the last twenty years in biotechnology building, leading and motivating process development and manufacturing teams to support clinical programs from early development to late stage clinical trials.   Michael has been responsible for cellular and viral process development and analytics, cGMP manufacturing operations, CMC regulatory strategy and process validation activities for multiple novel cell and gene therapy products. Currently, Michael is the Chief Operating Officer at ElevateBio, BaseCamp leading the operations for a broad portfolio of cell and cell therapy products and technologies.  Prior to ElevateBio, Michael was the Vice President of CMC operations at Oncorus and bluebird bio as the Head of Technical Operations and Cellular Process Development and Manufacturing Operations for all lentiviral vector-based autologous hematopoietic stem cell and CAR T cell programs.

Michael received his Bachelor of Science degree from Providence College and his Masters in Biochemistry and Molecular Biology from the University of New Hampshire.